01 1ScinoPharm Taiwan Ltd.
01 1Zotarolimus
01 1Taiwan
NDC Package Code : 65129-2096
Start Marketing Date : 2006-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
51
PharmaCompass offers a list of Zotarolimus API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zotarolimus manufacturer or Zotarolimus supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zotarolimus manufacturer or Zotarolimus supplier.
PharmaCompass also assists you with knowing the Zotarolimus API Price utilized in the formulation of products. Zotarolimus API Price is not always fixed or binding as the Zotarolimus Price is obtained through a variety of data sources. The Zotarolimus Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zotarolimus manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zotarolimus, including repackagers and relabelers. The FDA regulates Zotarolimus manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zotarolimus API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zotarolimus supplier is an individual or a company that provides Zotarolimus active pharmaceutical ingredient (API) or Zotarolimus finished formulations upon request. The Zotarolimus suppliers may include Zotarolimus API manufacturers, exporters, distributors and traders.
click here to find a list of Zotarolimus suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zotarolimus as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zotarolimus API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zotarolimus as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zotarolimus and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zotarolimus NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zotarolimus suppliers with NDC on PharmaCompass.
We have 1 companies offering Zotarolimus
Get in contact with the supplier of your choice:
